Myriad Genetics (MYGN) Buildings (2015 - 2019)

Myriad Genetics (MYGN) has 5 years of Buildings data on file, last reported at $18.2 million in Q3 2019.

• Buildings for Q3 2019 came in at $18.2 million, down 3.7% year-over-year; the trailing twelve-month figure through Sep 2019 was $18.2 million (down 3.7% YoY), and the FY2019 annual result was $18.8 million, down 2.59% from the prior year.
• Buildings fell to $18.2 million in Q3 2019 per MYGN's latest filing, from $18.8 million in the prior quarter.
• Over five years, Buildings peaked at $20.5 million in Q1 2018 and troughed at $16.1 million in Q4 2016.
• A 5-year average of $18.2 million and a median of $18.2 million in 2015 frame the typical range for Buildings.
• The sharpest annual moves came in 2017 and 2018: Buildings fell 13.3% in 2017, then gained 25.77% in 2018.
• A 5-year view of Buildings shows it stood at $17.3 million in 2015, then dropped by 6.94% to $16.1 million in 2016, then grew by 22.98% to $19.8 million in 2017, then retreated by 4.55% to $18.9 million in 2018, then dropped by 3.7% to $18.2 million in 2019.
• Business Quant data shows MYGN's Buildings at $18.2 million in Q3 2019, $18.8 million in Q2 2019, and $18.6 million in Q1 2019.